Related Experiment Video
Updated: May 30, 2026

09:25
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Primary graft failure after heart transplantation
Arjun Iyer1, Gayathri Kumarasinghe, Mark Hicks
1Heart & Lung Transplant Unit, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Journal of Transplantation
|August 13, 2011
Summary
Primary graft failure (PGF) after heart transplantation remains a leading cause of early death. Advances in treatment offer hope, but increased use of marginal donors heightens PGF risk, necessitating further research.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Primary graft failure (PGF) is a critical complication post-heart transplant, characterized by donor heart dysfunction.
- PGF significantly contributes to mortality and morbidity in the immediate postoperative phase.
- Despite treatment advancements, PGF remains the primary cause of death within 30 days of heart transplantation.
Purpose of the Study:
- To review the current landscape of primary graft failure in heart transplantation.
- To highlight the impact of utilizing marginal donors on PGF incidence.
- To underscore the need for improved prediction, prevention, and treatment strategies for PGF.
Main Methods:
- Literature review of recent advancements in PGF management.
- Analysis of trends in heart transplantation, including donor selection and PGF rates.
- Synthesis of current research on predicting and preventing PGF.
Main Results:
- Pharmacological treatments and mechanical circulatory support have improved outcomes for PGF patients.
- The increasing use of marginal donors correlates with a higher incidence of PGF.
- PGF continues to be the leading cause of early mortality post-heart transplant.
Conclusions:
- Effective prediction and prevention of PGF are crucial, especially with marginal donor utilization.
- Further research into novel treatment modalities for PGF is essential.
- Addressing PGF is vital to improve long-term success rates in heart transplantation.

